High SET protein levels are also associated with poor prognosis of metastatic colon cancer, non-small-cell lung cancer, pancreatic cancer, gastric cancer, liver cancer, CML, AML, and lymphoma16–22. Here, SET is linked to chronic myelogenous leukemia, BCR-ABL1 positive.